Also from this source

You just read:

Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon

News provided by

Boehringer Ingelheim Pharmaceuticals

Oct 30, 2010, 09:00 ET